GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (LTS:0R44) » Definitions » Equity-to-Asset

C-Rad AB (LTS:0R44) Equity-to-Asset : 0.68 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is C-Rad AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. C-Rad AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr290.9 Mil. C-Rad AB's Total Assets for the quarter that ended in Mar. 2024 was kr429.4 Mil. Therefore, C-Rad AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.68.

The historical rank and industry rank for C-Rad AB's Equity-to-Asset or its related term are showing as below:

LTS:0R44' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.38   Med: 0.68   Max: 0.81
Current: 0.68

During the past 13 years, the highest Equity to Asset Ratio of C-Rad AB was 0.81. The lowest was 0.38. And the median was 0.68.

LTS:0R44's Equity-to-Asset is ranked better than
56.16% of 869 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs LTS:0R44: 0.68

C-Rad AB Equity-to-Asset Historical Data

The historical data trend for C-Rad AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Rad AB Equity-to-Asset Chart

C-Rad AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.74 0.75 0.72 0.67

C-Rad AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.73 0.69 0.67 0.68

Competitive Comparison of C-Rad AB's Equity-to-Asset

For the Medical Devices subindustry, C-Rad AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-Rad AB's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where C-Rad AB's Equity-to-Asset falls into.



C-Rad AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

C-Rad AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=271.18/405.536
=0.67

C-Rad AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=290.9/429.4
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C-Rad AB  (LTS:0R44) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


C-Rad AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of C-Rad AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


C-Rad AB (LTS:0R44) Business Description

Traded in Other Exchanges
Address
Sjukhusvägen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. The operating segments of the group are the Positioning segment which includes development and sales of products in the field of patient positioning during radiotherapy, including catalyst, sentinel, and HIT lasers; and the Imaging segment which includes the development of imaging devices and detectors for cancer treatments and dosimetry. It generates maximum revenue from the Positioning segment. The firm sells its products in Sweden and internationally.

C-Rad AB (LTS:0R44) Headlines

No Headlines